Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
16 Dec 2014

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014

Adding ultrasound to routine mammography improves cancer detection in dense breasts

Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA
Adding ultrasound to routine mammography improves cancer detection in dense breasts ( Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA )
12 Dec 2014

CLL at ASH 2014: Expert discussion

Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
12 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014

Hope for avoiding chemo in patients with Hodgkins lymphoma

Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Hope for avoiding chemo in patients with Hodgkins lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014

ASH 2014: Highlights in mantle cell lymphoma

Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014

Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults

Dr Wendy Stock - University of Chicago, Chicago, USA
Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults ( Dr Wendy Stock - University of Chicago, Chicago, USA )
7 Dec 2014